Development And Characterization Of Solid Lipid Nanoparticles Of Anti-Inflammatory Drug For Ocular Drug Delivery System

Authors

  • Farhad F Mehta
  • Neha Singh
  • Vinay Pandit
  • Rajeev Garg
  • Sukirti Upadhyay
  • Rama Rao
  • Praveen Kumar Ashok
  • Kamalesh Tripathi

Keywords:

Flurbiprofen, Anti-inflammatory drug, Solid lipid nanoparticle, In vitro study

Abstract

By creating and testing flurbiprofen-solid lipid nanoparticle (SLN) loaded to enhance its therapeutic activity and lower dosage frequency to aid patient compliance, this study sought to create a novel topical ocular system of flurbiprofen.  Lipids and Tween 80 or Poloxamer 180 as stabilisers were used to create SLNs utilising ultrasonic and modified high shear homogenisation methods.  Particle size (PS), zeta potential (ZP), polydispersity index (PI), entrapment efficiency percentage (EE %), percentage of drug content, and in-vitro drug release were all measured and recorded for the manufactured SLNs.  A transmission electron microscope (TEM) was used to do the morphological analysis of the selected SLNs. An FTIR compatibility investigation was conducted.  According to the in-vitro drug release data, it was evident that the rate of drug release from SLN lasted for 10 hours when compared to plain medication. This suggested that the flurbiprofen-SLN loaded was able to regulate the flurbiprofen release rate.  The results showed that, in contrast to the ocular drug delivery system, FF5 offered an efficient pharmaceutical system with a regulated release.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Veloso DF, Benedetti NI, Ávila RI, Bastos TS, Silva TC, Silva MR, Batista AC, Valadares MC, Lima EM. Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity. Drug delivery. 2018 Jan 1;25(1):1585-94

Arpicco S., Dosio F., Stella B., Cattel L. Anticancer prodrugs: An overview of major strategies and recent developments. Curr. Top. Med. Chem. 2011;11:2346–2381. doi: 10.2174/156802611797183221.

Maksimenko A., Dosio F., Mougin J., Ferrero A., Wack S., Reddy L.H., Weyn A.-A., Lepeltier E., Bourgaux C., Stella B., et al. A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity. Proc. Natl. Acad. Sci. USA. 2014;111:E217–E226. doi: 10.1073/pnas.1313459110.

Sobot D., Mura S., Yesylevskyy S.O., Dalbin L., Cayre F., Bort G., Mougin J., Desmaële D., Lepetre-Mouelhi S., Pieters G., et al. Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery. Nat. Commun. 2017;8:15678. doi: 10.1038/ncomms15678.

Sobot D., Mura S., Rouquette M., Vukosavljevic B., Cayre F., Buchy E., Pieters G., Garcia-Argote S., Windbergs M., Desmaële D., et al. Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells. Mol. Ther. 2017;25:1596–1605. doi: 10.1016/j.ymthe.2017.05.016.

Hussein AA. Ex-vivo Ex-Vivo Absorption Study of a Novel Dabigatran Etexilate Loaded Nanostructured Lipid Carrier Using Non-Everted Intestinal Sac Model. Iraqi Journal of Pharmaceutical Sciences (IJPS). 2019 Dec 22;28(2):37-45.

Das S, Ng WK, Kanaujia P, Kim S, Tan RB. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids and surfaces b: biointerfaces. 2011 Nov 1;88(1):483-9.

Shah RM, Malherbe F, Eldridge D, Palombo EA, Harding IH.Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique. Journal of colloid and interface science. 2014 Aug 15;428:286-94.

Mandal S, Vishvakarma P, Verma M, Alam MS, Agrawal A, Mishra A. Solanum Nigrum Linn: an analysis of the Medicinal properties of the plant. Journal of Pharmaceutical Negative Results. 2023 Feb 1;14.

Sohail MF, Akhtar Shah P, Tariq I, Saeedul-Hassan A, Amin U, Raza S, et al. Development and in vitro evaluation of flurbiprofen microcapsules prepared by a modified solvent evaporation technique. Trop J Pharm Res 2014;13:1031-8.

Vishvakarma P. Design and development of montelukast sodium fast dissolving films for better therapeutic efficacy. Journal of the Chilean Chemical Society. 2018 Jun;63(2):3988-93

Patro N.M., Devi K., Pai R.S., Suresh S. Evaluation of bioavailability, efficacy, and safety profile of doxorubicin-loaded solid lipid nanoparticles. J. Nanopart. Res. 2013;15:2124. doi: 10.1007/s11051-013-2124-1.

Ma P., Mumper R.J. Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review. Nano Today. 2013;8:313–331. doi: 10.1016/j.nantod.2013.04.006.

Kang K.W., Chun M.-K., Kim O., Subedi R.K., Ahn S.-G., Yoon J.-H., Choi H.-K. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomed. Nanotechnol. Biol. Med. 2010;6:210–213. doi: 10.1016/j.nano.2009.12.006.

Laquintana V., Trapani A., Denora N., Wang F., Gallo J.M., Trapani G. New strategies to deliver anticancer drugs to brain tumors. Expert Opin. Drug Deliv. 2009;6:1017–1032. doi: 10.1517/17425240903167942.

Battaglia L., Muntoni E., Chirio D., Peira E., Annovazzi L., Schiffer D., Mellai M., Riganti C., Salaroglio I.C., Lanotte M., et al. Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: Preliminary study for glioma treatment. Nanomedicine. 2017;12:639–656. doi: 10.2217/nnm-2016-0380.

Stevens P.J., Sekido M., Lee R.J. A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm. Res. 2004;21:2153–2157. doi: 10.1007/s11095-004-7667-5.

Neves A.R., Queiroz J.F., Lima S.A.C., Reis S. Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways. Bioconj. Chem. 2017;28:995–1004. doi: 10.1021/acs.bioconjchem.6b00705.

Chirio D., Gallarate M., Peira E., Battaglia L., Serpe L., Trotta M. Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. J. Microencapsul. 2011;28:537–548. doi: 10.3109/02652048.2011.590615.

Irby D., Du C., Li F. Lipid-Drug Conjugate for Enhancing Drug Delivery. Mol. Pharm. 2017;14:1325–1338. doi: 10.1021/acs.molpharmaceut.6b01027.

Scholes P.D., Coombes A.G.A., Illum L., Davis S.S., Watts J.F., Ustariz C., Vert M., Davies M.C. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J. Control. Release. 1999;59:261–278. doi: 10.1016/S0168-3659(98)00138-2.

Peira E., Chirio D., Battaglia L., Barge A., Chegaev K., Gigliotti C.L., Ferrara B., Dianzani C., Gallarate M. Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: Preparation, characterization, and in vitro cytotoxicity studies. J. Microencapsul. 2016;33:381–390. doi: 10.1080/02652048.2016.1202342.

Vishvakrama P, Sharma S. Liposomes: an overview. Journal of Drug Delivery and Therapeutics. 2014;4(3):47-55.

Vishvakarma P, Kumari R, Vanmathi SM, Korni RD, Bhattacharya V, Jesudasan RE, Mandal S. Oral delivery of peptide and protein therapeutics: challenges and strategies. Journal of Experimental Zoology India. 2023 Jul 1;26(2).

Gaffney JS, Marley NA, Jones DE. Fourier transform infrared (FTIR) spectroscopy. Characterization of Materials. 2002 Oct 15:1-33.

Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. The AAPS journal. 2010 Sep;12(3):348-60.

Taveira SF, Gelfuso GM, Lima EM, Gratieri T. Liposomal voriconazole (VOR) formulation for improved ocular delivery. Colloids and Surfaces B: Biointerfaces. 2015 Sep 1;133:331-8.

Vishvakarma P, Kaur J, Chakraborthy G, Vishwakarma DK, Reddy BB, Thanthati P, Aleesha S, Khatoon Y. Nephroprotective potential of terminalia arjuna against cadmium-induced renal toxicity by in-vitro study. Journal of Experimental Zoology India. 2025 Jan 1;28(1).

Vishvakarma P, Mohapatra L, Kumar NN, Mandal S, Mandal S. An innovative approach on microemulsion: A review. European Chemical Bulletin. 2023;12(4):11710-33Alruwaili NK, Imam SS, Alotaibi NH, Alhakamy NA, Alharbi KS, Alshehri S, Afzal M, Alenezi SK, Bukhari SN. Formulation of chitosan polymeric vesicles of ciprofloxacin for ocular delivery: box-behnken optimization, in vitro characterization, HET-CAM irritation, and antimicrobial assessment. AAPS PharmSciTech. 2020 Jul;21(5):1-6.

Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN). Journal of microencapsulation. 2001 Jan 1;18(2):149-58

Downloads

Published

2025-05-20

How to Cite

1.
F Mehta F, Singh N, Pandit V, Garg R, Upadhyay S, Rao R, Kumar Ashok P, Tripathi K. Development And Characterization Of Solid Lipid Nanoparticles Of Anti-Inflammatory Drug For Ocular Drug Delivery System. J Neonatal Surg [Internet]. 2025May20 [cited 2025Sep.24];14(7):702-9. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/6168

Most read articles by the same author(s)